RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Nary any sellersmooolaaaa wrote: Buying established companies is cheaper and more efficient than starting from scratch. These companies have established clientele, manufacturers, goodwill etc. Why would anyone start from scratch?
IMO the healthcare sector in general is in a correction. Investors are putting enormous pressure on MT to get the SP going. MT knows that in 3-5 years Concordia will be a billion dollar company but people ( like everyone on this board ) can't wait that long. So MT puts the company up for sale, probably knowing that it will take many quarters to sell Concordia, meanwhile MT will show the market that Concordia is able to make a lot of money.... And the SP will re rate.....
Now stop making assumptions and predictions you bunch of dic licking pricks...... If I'm wrong I will pay dearly... But if I'm right..... Hallelujah Jesus, hoooorrraaaa
Yes you are.
One thing to keep in mind that a friend pointed out, is that since there is so much negativity and bad news in the sector, no Pharma will invest new money into competing with established generics in this environment. Where there's an action there's a reaction. This has brought about an unexpected reaction where competition will actually die off because the risks are too high and rewards poor to compete.
For those that are established as Concordia's AMCo, it will provide years of relief in the competitive arena and ensure a monopoly environment in many areas of the world.